ARKG is trading at $47.44 (-3.66%) as September CPI exceeded expectations, reviving higher-for-longer rate concerns.
- The broader healthcare sector was comparatively resilient on October 15, so the decline appears more consistent with pressure on ARKGβs concentrated genomics holdings than a sector-wide selloff.
- Its largest positions include 10x Genomics, Twist Bioscience, and Tempus AI.